Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action

1. The topoisomerase II inhibitor amsacrine is used in the treatment of acute myelogenous leukemia. Although most anticancer drugs are believed not to cause acquired long QT syndrome (LQTS), concerns have been raised by reports of QT interval prolongation, ventricular fibrillation and death associat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thomas, Dierk, Hammerling, Bettina C, Wu, Kezhong, Wimmer, Anna-Britt, Ficker, Eckhard K, Kirsch, Glenn E, Kochan, Mary C, Wible, Barbara A, Scholz, Eberhard P, Zitron, Edgar, Kathöfer, Sven, Kreye, Volker A W, Katus, Hugo A, Schoels, Wolfgang, Karle, Christoph A, Kiehn, Johann
Format: Artigo
Idioma:Inglês
Publicat: 2004
Matèries:
Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1574964/
https://ncbi.nlm.nih.gov/pubmed/15148258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705795
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars